Methadone maintenance treatment (MMT) has been used to treat opiate dependence since the mid-1960s. Previous studies have investigated the effects of methadone on cognitive function however the findings have been inconsistent. Some report a complete absence of deficits while others report different types of cognitive impairment. Our research aimed to investigate the effects of MMT on cognitive function by comparing the performance of patients currently enrolled in MMT (n=32) with opiate-dependent subjects (n=17) and healthy control subjects (n=25) on a computerised neuropsychological test battery. Both the patients undertaking MMT and the opiate users showed less efficient interaction between visual searching and manually connecting digits and letters during the Switching of Attention Task than the healthy control subjects (F(2,64)=3.25, p=0.05), which indicates deficits in information processing. Nevertheless, the performance of the MMT group was similar to that of healthy control subjects in all other tasks, in contrast to the group of opiate users who performed poorly when compared to healthy control subjects during tests of attention (mean difference (MD)=2.8, 95% confidence interval (CI) (0.9–4.7), p=0.001) and executive function (MD=5.9, 95% CI (1.3–10.5), p=0.007). These findings suggest that cognitive function in patients undertaking MMT is improved compared to those dependent on illicit opiates.
AharonovichENunesEHasinD (2003) Cognitive impairment, retention and abstinence among cocaine abusers in cognitive-behavioral treatment. Drug Alcohol Depend71: 207–211.
2.
American Psychiatric Association (2000) Diagnostic and Statistical Manual of Mental Disorders, Fourth Edition - Text Revision (DSMIV-TR)USA: American Psychiatric Association.
3.
AppelPGordonN. (1976) Digit-symbol performance in methadone-treated ex-heroin addicts. Am J Psychiatry133: 1337–1340
4.
AppelPW (1982) Sustained attention in methadone patients. Subst Use Misuse17: 1313–1327.
5.
ArbuthnottKFrankJ (2000) Trail Making Test, Part B as a measure of executive control: Validation using a set-switching paradigm. J Clin Exp Neuropsychol22: 518–528.
6.
ArgeriouMMcCartyDMulveyK. (1994) Use of the addiction severity index with homeless substance abusers. J Subst Abuse Treat11: 359–365.
7.
BaldacchinoABalfourDJKPassettiF. (2012) Neuropsychological consequences of chronic opioid use: A quantitative review and meta-analysis. Neurosci Biobehav Rev36: 2056–2068.
8.
BallJCLangeWRMyersCP. (1988) Reducing the risk of AIDS through methadone maintenance treatment. J Health Soc Behav29: 214–226.
9.
BlakeADBotGFreemanJC. (1997) Differential opioid agonist regulation of the mouse μ opioid receptor. J Biol Chem272: 782–790.
10.
ClairJMartinLBondAJ. (2009) An experimental study of aggressive and neutral interpretative bias in opiate-dependent and opiate-abstinent men. J Psychopharmacol23: 428–435.
11.
ClarkCRPaulRHWilliamsLM. (2006) Standardized assessment of cognitive functioning during development and aging using an automated touchscreen battery. Arch Clin Neuropsychol21: 449–467.
12.
CohenJ (1988) Statistical Power Analysis for the Behavioral Sciences. 2nd ed.Hillsdale, New Jersey: Lawrence Earlbaum Associates.
13.
ConcaAJWorthenDR (2012) Nonprescription drug abuse. J Pharm Pract25: 13–21.
14.
CurranHVBoltonJWanigaratneS. (1999) Additional methadone increases craving for heroin: A double-blind, placebo-controlled study of chronic opiate users receiving methadone substitution treatment. Addiction94: 665–674.
15.
CurranHVKleckhamJBearnJ. (2001) Effects of methadone on cognition, mood and craving in detoxifying opiate addicts: A dose-response study. Psychopharmacology154: 153–160.
16.
DanionJMWeingartnerHFileSE. (1993) Pharmacology of human memory and cognition: Illustrations from the effects of benzodiazepines and cholinergic drugs. J Psychopharmacol7: 371–377.
17.
DarkeSSimsJMcDonaldS. (2000) Cognitive impairment among methadone maintenance patients. Addiction95: 687–695.
18.
DavisPELiddiardHMcMillanTM (2002) Neuropsychological deficits and opiate abuse. Drug Alcohol Depend67: 105–108.
19.
DayEStrangJ (2011) Outpatient versus inpatient opioid detoxification: A randomized controlled trial. J Subst Abuse Treat40: 56–66.
20.
De QuervainDJFRoozendaalBMcGaughJL (1998) Stress and glucocorticoids impair retrieval of long-term spatial memory. Nature394: 787–790.
21.
ErscheKDSahakianBJ (2007) The neuropsychology of amphetamine and opiate dependence: Implications for treatment. Neuropsychology Review17: 317–336.
22.
ErscheKDRoiserJPClarkL. (2005 ) Punishment induces risky decision-making in methadone-maintained opiate users but not in heroin users or healthy volunteers. Neuropsychopharmacology30: 2115–2124.
23.
European Monitoring Centre for Drugs and Drug Addiction (2012) Table HSR-3. Estimated number of clients in methadone treatment and of all clients receiving any opioid substitution treatment (OST). Available at: http://www.emcdda.europa.eu/stat12. (accessed 27 May 2013).
24.
FingelkurtsAAFingelkurtsAAKivisaariR. (2009) Methadone restores local and remote EEG functional connectivity in opioid. Int J Neurosci119: 1469–1493.
25.
GibsonDRFlynnNMMcCarthyJJ (1999 ) Effectiveness of methadone treatment in reducing HIV risk behavior and HIV seroconversion among injecting drug users. AIDS13: 1807–1818.
26.
GordonNB (1970) Reaction-times of methadone treated ex heroin addictsPsychopharmacology16: 337–344.
27.
GossopMStewartDBrowneN. (2002) Factors associated with abstinence, lapse or relapse to heroin use after residential treatment: Protective effects of coping responses. Addiction97: 1259–1267.
28.
GrevertPMasoverBGoldsteinA (1977) Failure of methadone and levomethadyl acetate (levo-alpha-acetylmethadol, LAAM) maintenance to affect memory. Arch Gen Psychiatry34: 849–853.
29.
GritzERShiffmanSMJarvikME. (1975) Physiological and psychological effects of methadone in man. Arch Gen Psychiatry32: 237–242.
30.
HeffelfingerAKNewcomerJW (2001) Glucocorticoid effects on memory function over the human life span. Dev Psychopathol13: 491–513.
31.
JamesBWayneHKarenB (2006) Changes in criminal activity after entering methadone maintenance. Br J Addict87: 251–258.
32.
JosephHStancliffSLangrodJ (2000) Methadone maintenance treatment (MMT): A review of historical and clinical issues. Mt Sinai J Med67: 347–364.
33.
JunHMohammedSHussainiQ. (2012) Functional role of adult hippocampal neurogenesis as a therapeutic strategy for mental disorders. Neural Plasticity. vol. 2012, Article ID 854285, 20 pages, doi:10.1155/2012/854285.
34.
KempAHCooperNHermensG. (2005) Toward an integrated profile of emotional intelligence: Introducing a brief measure. J Integr Neurosci4: 41–61.
35.
KesslerRUstünT (2004) The World Mental Health (WMH) Survey Initiative Version of the World Health Organization (WHO) Composite International Diagnostic Interview (CIDI). Int J Methods Psychiatr Res13: 93–121.
36.
KirschbaumCWolfOTMayM. (1996) Stress- and treatment-induced elevations of cortisol levels associated with impaired declarative memory in healthy adults. Life Sci58: 1475–1483.
37.
KouriELukasSMendelsonJ (1996) P300 assessment of opiate and cocaine users: Effects of detoxification and buprenorphine treatment. Biol Psychiatry40: 617–628.
38.
KreekM (1996) Opioid receptors: Some perspectives from early studies of their role in normal physiology, stress responsivity, and in specific addictive diseases. Neurochem Res21: 1469–1488.
39.
KreekMJKoobGF (1998) Drug dependence: Stress and dysregulation of brain reward pathways. Drug Alcohol Depend51: 23–47.
40.
LeeSKawachiIBerkmanLF. (2002) Education, other socioeconomic indicators, and cognitive function. Am J Epidemiol157: 712–720.
41.
LeonhardCMulveyKGastfriendD. (2000) The Addiction Severity Index: A field study of internal consistency and validity. J Subst Use18: 129–135.
42.
LiuJLiaoXGongZ. (1999) The difference between methadone and morphine in regulation of δ-opioid receptors underlies the antagonistic effect of methadone on morphine-mediated cellular actions. Eur J Pharmacol373: 233–239.
43.
LoeberSKniestADiehlA. (2008) Neuropsychological functioning of opiate-dependent patients: A nonrandomized comparison of patients preferring either buprenorphine or methadone maintenance treatment. Am J Drug Alcohol Abuse34: 584–593.
44.
LombardoWKLombardoBGoldsteinA (1976) Cognitive functioning under moderate and low dosage methadone maintenance. Int J Addict11: 389–401.
45.
MarschLA (1998) The efficacy of methadone maintenance interventions in reducing illicit opiate use, HIV risk behavior and criminality: A meta-analysisAddiction93: 515–532.
46.
MartinsSSStorrCLZhuH. (2009) Correlates of extramedical use of OxyContin® versus other analgesic opioids among the US general population. Drug Alcohol Depend99: 58–67.
47.
McDermottPABrownLZaballeroA. (1996) Construct refinement and confirmation for the addiction severity index. Psychol Assess8: 182–189.
48.
McLellanATLuborskyLO’BrienCP. (1980) An improved diagnostic instrument for substance abuse patients: The Addiction Severity Index. J Nerv Ment Dis168: 26–33.
49.
Ministry of Education (2010) Educational Attainment in the Adult Population. Wellington. New Zealand: Ministry of Education.
50.
MintzerMZStitzerML (2002) Cognitive impairment in methadone maintenance patients. Drug Alcohol Depend67: 41–51.
51.
MintzerMZCopersinoMLStitzerML (2005) Opioid abuse and cognitive performance. Drug Alcohol Depend78: 225–230.
52.
NovickDMOchshornMGhaliV. (1989) Natural killer cell activity and lymphocyte subsets in parenteral heroin abusers and long-term methadone maintenance patients. J Pharmacol Exp Ther250: 606–610.
53.
PaulRLawrenceJWilliamsL. (2005) Preliminary validity of ‘IntegNeuro’: A new computerized battery of neurocognitive testsInt J Neurosci115: 1549–1567.
54.
PirastuRFaisRMessinaM. (2006) Impaired decision-making in opiate-dependent subjects: Effect of pharmacological therapies. Drug Alcohol Depend83: 163–168.
55.
ProsserJCohenLJSteinfeldM. (2006) Neuropsychological functioning in opiate-dependent subjects receiving and following methadone maintenance treatment. Drug Alcohol Depend84: 240–247.
56.
ProsserJLondonEGalynkerI (2009) Sustained attention in patients receiving and abstinent following methadone maintenance treatment for opiate dependence: Performance and neuroimaging results. Drug Alcohol Depend104: 228–240.
57.
RapeliPFabritiusCAlhoH. (2007) Methadone vs. buprenorphine/naloxone during early opioid substitution treatment: A naturalistic comparison of cognitive performance relative to healthy controls. BMC Clin Pharmacol7: 5.
58.
RapeliPFabritiusCKalskaH. (2009) Memory function in opioid-dependent patients treated with methadone or buprenorphine along with benzodiazepine: Longitudinal change in comparison to healthy individuals. Subst Abuse Treat Prev Policy4: 1–15.
59.
ReitanR (1958) Validity of the Trail Making test as an indicator of organic brain damage. Percept Mot Skills8: 271–276.
RothenbergSMeyerRERaussB. (1977) Performance differences between addicts and non-addicts. Psychopharmacology52: 299–306.
62.
RounsavilleBJAntonSFCarrollK. (1991) Psychiatric diagnoses of treatment-seeking cocaine abusers. Arch Gen Psychiatry48: 43–51.
63.
SankararamanAMasiulisIRichardsonDR. (2012) Methadone does not alter key parameters of adult hippocampal neurogenesis in the heroin-naïve rat. Neurosci Lett516: 99–104.
64.
SchindlerSDOrtnerRPeternellA. (2004) Maintenance therapy with synthetic opioids and driving aptitude. European Addiction Research10: 80–87.
65.
SellmanD (2006) Improving treatment for people with addiction problems in Aotearoa New Zealand. Inaugural Professional Lecture Series. Christchurch, New Zealand: Christchurch School of Medicine and Health Sciences.
66.
SoykaMLiebMKagererS. (2008) Cognitive functioning during methadone and buprenorphine treatment: Results of a randomized clinical trial. J Clin Psychopharmacol28: 699–703.
Standards Australia/Standards New Zealand. (2008) Australian/New Zealand Standard: Procedures for specimen collection and the detection and quantitation of drugs of abuse in urine. Sydeny: Standards Australia/Sstandards New Zealand.
69.
TurnerTHLaRoweSHornerMD. (2009) Measures of cognitive functioning as predictors of treatment outcome for cocaine dependence. J Subst Abuse Treat37: 328–334.
70.
VerdejoAToribioIOrozcoC. (2005) Neuropsychological functioning in methadone maintenance patients versus abstinent heroin abusers. Drug Alcohol Depend78: 283–288.
71.
Verdejo-GarcíaALópez-TorrecillasFGiménezCO. (2004) Clinical implications and methodological challenges in the study of the neuropsychological correlates of cannabis, stimulant, and opioid abuseNeuropsychol Rev14: 1–41.
72.
WilliamsLMHermensDFTheinT. (2010) Using brain-based cognitive measures to support clinical decisions in ADHD. Pediatr Neurol42: 118–126.
73.
Wittchen H-U (1994) Reliability and validity studies of the WHO-Composite International Diagnostic Interview (CIDI): A critical review. J Psychiatr Res28: 57–84.
Supplementary Material
Please find the following supplemental material available below.
For Open Access articles published under a Creative Commons License, all supplemental material carries the same license as the article it is associated with.
For non-Open Access articles published, all supplemental material carries a non-exclusive license, and permission requests for re-use of supplemental material or any part of supplemental material shall be sent directly to the copyright owner as specified in the copyright notice associated with the article.
